Delivery Order SPE2DB20D1004-SPE2DB25FNDXU

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,698.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product, with a completion date of November 20, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,697.66, is for the delivery of ANORO ELLIPTA 62.5-25 MCG INH 60S, a medical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. The award has a ceiling value of $1,577.43 and a completion date of August 20, 2024. The contract is a Firm Fixed Price arrangement. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,024.66 firm fixed-price delivery order is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product, with a performance period through April 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is a $12,987.26 firm fixed price delivery order for the ANORO ELLIPTA 62.5-25 MCG INH 60S pharmaceutical product. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company, for the delivery of ANORO ELLIPTA 62.5-25 MCG INH 60S, a respiratory medication. The contract has a ceiling value of $2,695.19 and an ultimate completion date of September 25, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., which is valued at up to...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution services company. The delivery order is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product, with a ceiling value of $9,344.68. The contract has an ultimate completion date of March 21, 2024 and was awarded on March 20, 2024. This delivery order falls...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. The contract has a ceiling value of $1,099.20 and is a firm fixed-price delivery order with a completion date of June 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product, with a ceiling value of $3,462.61 and a performance period through April 12, 2024. The contract was awarded as a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp, through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a prescription medication. The award has a ceiling value of $3,574.93 and an ultimate completion date of August 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNDXU
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,854.85 and is a delivery order under DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract provides for the delivery of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product, to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors. The contract has an ultimate completion date of January 6, 2025.

Generated 4/4/25, 10:42 AM